Physician profile
Robert K Abdullah
NPI 1700079100
$882.49
in general payments reported to CMS, 2019-2025
10 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $20.84 · 2021: $23.93 · 2022: $52.27 · 2023: $145 · 2024: $150 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $139.50 | 2019-2020 | |
| Advanced Respiratory, INC | $137.57 | 2019-2021 | |
| Chiesi USA, INC. | $128.47 | 2019 | |
| Janssen Pharmaceuticals, INC | $100.84 | 2022-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $97.34 | 2023-2025 | Eliquis |
| Pfizer INC. | $93.92 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.63 | 2023-2024 | Lifevest |
| Mallinckrodt Hospital Products INC. | $35.03 | 2025 | Terlivaz |
| Novartis Pharmaceuticals Corporation | $32.67 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Abdullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.